Webinar Replay
Sex, Libido, and Relationships: A Functional Medicine Approach
Presented by Sara Gottfried, MD
Hormonal issues are the root cause for 70 percent of people with sexual dysfunction. The main hormones involved include cortisol, estrogen, testosterone, DHEA, and thyroid hormones—even oxytocin and kisspeptin.
In this webinar, we will cover the normal sexual response for men and women, describe the types of male and female sexual dysfunction, identify the hormonal signatures of the most common types of sexual dysfunction, and review the evidence-based nonpharmacologic and pharmacologic treatments currently available.
About the Speaker
Sara Gottfried, MD, is a physician, researcher, and educator. She graduated from Harvard Medical School and MIT, and completed residency at UCSF, but is more likely to prescribe a CGM and personalized nutrition plan than the latest pharmaceutical. Dr. Gottfried is a global keynote speaker and the author of four New York Times bestselling books about trauma, hormones, and health. She is a clinical assistant professor in the Department of Integrative Medicine and Nutritional Sciences at Thomas Jefferson University, and director of Precision Medicine at the Marcus Institute of Integrative Health. Her focus is the interface of mental and physical health, N-of-1 trial design, personalized molecular profiling, use of wearables, and how to leverage these tools to improve health outcomes.
Key Moments
- 00.00 - 02.30 - Webinar Introduction
- 04.22 - How to ask patients the right questions to understand sexual wellness
- 06.20 - About 70% of patients with sexual dysfunction have a hormonal reason for it
- 06.40 - Defining what’s normal
- 11.40 - Important research on the female sexual response
- 15.55 - Transitioning from Normal to Dysfunction
- 24.25 - Common causes and risk factors of female sexual dysfunction
- 26.30 - Hormonal contributors to low desire in females
- 29.15 & 46.48 - DUTCH Test Case Studies
- 32.34 - Root causes and DSM classifications of female sexual dysfunction
- 39.15 - Supporting patients with sexual dysfunction
- 45.48 - Key takeaways from Rosemary Basson study
- 48.32 - Summary
- 49.43 - Q&A Begins
- 57.48 - Closing
